Business Description
Organovo Holdings Inc
NAICS : 541714
SIC : 2836
ISIN : US68620A1043
Description
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.71 | |||||
| Equity-to-Asset | 0.55 | |||||
| Debt-to-Equity | 0.32 | |||||
| Debt-to-EBITDA | -0.09 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | -76.04 | |||||
| Beneish M-Score | -3.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 12.7 | |||||
| 3-Year EPS without NRI Growth Rate | 13.1 | |||||
| 3-Year FCF Growth Rate | 6.9 | |||||
| 3-Year Book Growth Rate | -57.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 16.94 | |||||
| Future 3-5Y Total Revenue Growth Rate | 27.55 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 73.78 | |||||
| 9-Day RSI | 61.52 | |||||
| 14-Day RSI | 55.34 | |||||
| 6-1 Month Momentum % | -55.69 | |||||
| 12-1 Month Momentum % | -62.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.98 | |||||
| Quick Ratio | 1.72 | |||||
| Cash Ratio | 1.31 | |||||
| Days Inventory | 54547.22 | |||||
| Days Sales Outstanding | 140.33 | |||||
| Days Payable | 74727.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.1 | |||||
| Shareholder Yield % | -83.25 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 97.09 | |||||
| Operating Margin % | -12398.06 | |||||
| Net Margin % | -12176.7 | |||||
| FCF Margin % | -11473.79 | |||||
| ROE % | -219.41 | |||||
| ROA % | -147.15 | |||||
| ROIC % | -373.71 | |||||
| ROC (Joel Greenblatt) % | -648.29 | |||||
| ROCE % | -193.44 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 46.42 | |||||
| PB Ratio | 1.84 | |||||
| Price-to-Tangible-Book | 1.84 | |||||
| EV-to-EBIT | -0.36 | |||||
| EV-to-EBITDA | -0.37 | |||||
| EV-to-Revenue | 44.27 | |||||
| EV-to-Forward-Revenue | 22.69 | |||||
| EV-to-FCF | -0.39 | |||||
| Price-to-Net-Current-Asset-Value | 4 | |||||
| Price-to-Net-Cash | 44.04 | |||||
| Earnings Yield (Greenblatt) % | -277.78 | |||||
| FCF Yield % | -174.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ONVO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Organovo Holdings Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.103 | ||
| EPS (TTM) ($) | -1.06 | ||
| Beta | 1.22 | ||
| Volatility % | 37.8 | ||
| 14-Day RSI | 55.34 | ||
| 14-Day ATR ($) | 0.058645 | ||
| 20-Day SMA ($) | 0.40128 | ||
| 12-1 Month Momentum % | -62.55 | ||
| 52-Week Range ($) | 0.3154 - 1.74 | ||
| Shares Outstanding (Mil) | 15.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Organovo Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Organovo Holdings Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Organovo Holdings Inc Frequently Asked Questions
What is Organovo Holdings Inc(ONVO)'s stock price today?
The current price of ONVO is $0.44. The 52 week high of ONVO is $1.74 and 52 week low is $0.32.
When is next earnings date of Organovo Holdings Inc(ONVO)?
The next earnings date of Organovo Holdings Inc(ONVO) is 2025-02-07 Est..
Does Organovo Holdings Inc(ONVO) pay dividends? If so, how much?
Organovo Holdings Inc(ONVO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers